Once you have logged into the submission portal with your account, click on the “+New” button to start with your abstract submission.

Read through the affirmations carefully and confirm them.

SUBMISSION STEP 1: TITLE

• In the title, please use capital letters ONLY where necessary (e.g. "Detection of two novel large mutations in SLC7A9 by semi-quantitative fluorescent multiplex PCR").
• Please DO NOT line breaks in the title. Use italics only where required by nomenclature.
• The title is limited to 25 words!

SUBMISSION STEP 2: AFFIRMATION / ALLOCATION / TYPE

1. Confirm the affirmation regarding the registration.

2. Please indicate whether your abstract is a regular, encore or trial in progress abstract. For an encore abstract please fill in where the abstract has been published before (journal name, issue, name of congress…) and provide a rationale for the resubmission.

SUBMISSION STEP 3: TOPIC

Please allocate your submission to a suitable topic from the list provided. Select only ONE topic that best relates to the main subject of your abstract.

01. Tumour cell biology, heterogeneity and plasticity
02. Microenvironment
03. Imaging
04. Computational neuro-oncology
05. Advanced diagnostics and biomarkers
06. Neurocognition and connectome
07. Neurosurgery, drug delivery and advanced techniques
08. Immunotherapy
09. Radiation
10. Pediatric brain tumors
11. Brain metastasis and leptomeningeal disease
12. Adult glioma
13. Meningioma
14. Rare CNS tumors
15. Palliative and supportive care/QoL
16. Public cancer policies and patient involvement
17. Clinical neuro-oncology
18. Preclinical neuro-oncology

SUBMISSION STEP 4: KEYWORDS

• Please enter up to 3 keywords describing your work (at least 1 required).

SUBMISSION STEP 5: AUTHORS

• No more than 35 authors can be listed.
• A maximum of 2 affiliations per author is allowed.
• First you need to add the presenting author information. The contact details will be prepopulated from the profile information you supplied. In case you will not present the abstract at the congress, you can overwrite the information.
• In the next step you can add institutions, add co-authors, change who is presenting (marked in green), change the order of authors or add a consortium.
• To add a new author click on "Add Author" and check if the person is already in the system by entering their email address and clicking on "Search".
  • If the person is already in the system, you can select them from the provided list by clicking on "Add". Review the prepopulated contact information, add any missing information and potential conflicts of interest, save and continue.
  • If the person is not in the system yet, use the button "Enter your Author here!", add all information, save and continue.
• DISCLOSURE INFORMATION: In order to help readers form their own judgments of potential bias in published abstracts, submitters are asked to declare any competing financial interests of all authors. Contributions of up to EUR 10.000,- (or equivalent value in kind) per year per entity are considered "Modest". Contributions above EUR 10.000,- per year are considered "Significant".

SUBMISSION STEP 6: ABSTRACT TEXT

The abstract body should be structured as follows:

-  Background
-  Material and Methods
-  Results
-  Conclusion

Concerning the abstract format and structure please see the SAMPLE ABSTRACT.

• The text cannot exceed 2500 characters without spaces (350-400 words), excluding title and authors. Minimum 500 characters.
• The abstract must be submitted in good English.
• No tables, no graphics or illustrations are allowed.
• No literature must be cited.
• The text may be typed in or copy/pasted from an existing document.
• Special characters are widely supported.
• Support/Disclosure: Enter the source(s) of contributed support and/or grant numbers at the end of the abstract text section.

SUBMISSION STEP 7: PRESENTATION PREFERENCE

• During submission, authors can select whether they prefer an oral or poster presentation.
• Please indicate your preference, especially in case you do not want your abstract to be selected for an oral presentation.
• Note: This step does not apply to late breaking abstract submissions.

SUBMISSION STEP 8: MORE INFORMATION

Please indicate if

• you want to apply for a Travel Scholarship and select the Scholarship you are eligible for. Only applicable for abstract submissions within the regular submission (deadline April 2, 2026);
• you would like to be considered to publish a manuscript related to your abstract in Neuro-Oncology or The Lancet Group;
• indicate if you are a Nurse/AHP submitting an abstract.
• Note: This step does not apply to late breaking abstract submissions.

SUBMISSION STEP 9: SUBMISSION SUMMARY

• The summary page will display all information related to your abstract.
• You may save the summary page for your records as a PDF. The system also has an e-mail confirmation feature. Simply click the appropriate link on the summary page and fill in your email address(es) in the appropriate box.
• If you choose to delete the submission, this can be made here. Please note that you will not be able to retrieve deleted submissions.

CORRECTIONS / WITHDRAWALS OF ABSTRACTS

• Titles of submitted abstracts are displayed on your submission site, together with the information on whether the submission is complete or incomplete. To edit one of your abstracts, simply click on the title.
• Submitted abstracts can be corrected / withdrawn via the online submission portal until the submission deadline of April 2, 2026.
• Corrections or withdrawals after the deadline have to be requested in an email to eano-meetings@eano.eu
• No corrections / withdrawals are possible after April 2, 2026.